Amantadine hydrochloride 100 MG Oral Tablet — RxCUI 849395
RxNorm drug concept · Semantic clinical drug
RxCUI 849395
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
20 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI849395
Official nameAmantadine hydrochloride 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamantadine HCl 100 MG Oral Tablet
FDA products mapped12
Package NDCs mapped20
Reported Medicaid activity (SDUD)80,652 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Amantadine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Standard amantadine capsules, tablets and oral solution prevent and treat influenza A and treat parkinsonism and drug-induced movement problems. Gocovri...
- Take it by mouth exactly as your prescriber directs. Standard forms can be taken once a day or split into two doses. Gocovri is taken at bedtime and swallowed whole, with or withou...
- Common ones include dizziness, dry mouth, constipation, leg swelling, and sometimes hallucinations. Stand up slowly to avoid lightheadedness. Call me or your doctor if you see thin...
- Call for thoughts of suicide, new depression, hallucinations, fainting, falling asleep during daily activities, or sudden blurry vision or eye pain. Also call about uncontrollable...
🕸️ Concept Web — How Amantadine hydrochloride 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Amantadine hydrochloride 100 MG Oral Tablet
RxCUI 849395 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Amantadine
620IN -
Amantadine hydrochloride
282415PIN
-
Amantadine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Amantadine Oral Tablet
370559SCDF -
Amantadine hydrochloride Oral Tablet
2646928SCDFP -
Amantadine Oral Product
1151229SCDG -
Amantadine Pill
1151230SCDG -
Amantadine hydrochloride Oral Product
2659287SCDGP -
Amantadine hydrochloride Pill
2662566SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Amantadine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Amantadine hydrochloride 100 MG
849388SCDC
-
Amantadine hydrochloride 100 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Amantadine hydrochloride 100 MG
SCDC · 849388 -
Amantadine Oral Tablet
SCDF · 370559 -
Amantadine hydrochloride Oral Tablet
SCDFP · 2646928 -
Amantadine Oral Product
SCDG · 1151229 -
Amantadine Pill
SCDG · 1151230 -
Amantadine hydrochloride Oral Product
SCDGP · 2659287 -
Amantadine hydrochloride Pill
SCDGP · 2662566
📦 FDA Products & Package NDCs
12 products · 20 package NDCs
20 package NDCs map to RxCUI 849395 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00615-8605-39 | 30 TABLET in 1 BLISTER PACK (0615-8605-39) | Amantadine | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-01-20 |
| 00832-0111-00 | 100 TABLET in 1 BOTTLE (0832-0111-00) | Amantadine Hydrochloride | Upsher-Smith Laboratories, LLC | 2011-12-15 |
| 00832-0111-03 | 100 BLISTER PACK in 1 CARTON (0832-0111-03) / 1 TABLET in 1... | Amantadine Hydrochloride | Upsher-Smith Laboratories, LLC | 2017-07-07 |
| 00832-0111-50 | 500 TABLET in 1 BOTTLE (0832-0111-50) | Amantadine Hydrochloride | Upsher-Smith Laboratories, LLC | 2011-12-15 |
| 10135-0692-01 | 100 TABLET in 1 BOTTLE (10135-692-01) | Amantadine Hydrochloride | Marlex Pharmaceuticals Inc | 2020-03-01 |
| 10135-0692-05 | 500 TABLET in 1 BOTTLE (10135-692-05) | Amantadine Hydrochloride | Marlex Pharmaceuticals Inc | 2020-03-01 |
| 10135-0693-01 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (10135-693-01) | Amantadine Hydrochloride | Marlex Pharmaceuticals Inc | 2020-03-01 |
| 10135-0693-05 | 500 CAPSULE, GELATIN COATED in 1 BOTTLE (10135-693-05) | Amantadine Hydrochloride | Marlex Pharmaceuticals Inc | 2020-03-01 |
| 42543-0497-01 | 100 TABLET in 1 BOTTLE (42543-497-01) | Amantadine Hydrochloride | Strides Pharma Inc. | 2017-08-04 |
| 42543-0497-05 | 500 TABLET in 1 BOTTLE (42543-497-05) | Amantadine Hydrochloride | Strides Pharma Inc. | 2017-08-08 |
| 46708-0586-31 | 100 TABLET in 1 BOTTLE (46708-586-31) | Amantadine | Alembic Pharmaceuticals Limited | 2020-10-20 |
| 46708-0586-71 | 500 TABLET in 1 BOTTLE (46708-586-71) | Amantadine | Alembic Pharmaceuticals Limited | 2020-10-20 |
| 62332-0586-31 | 100 TABLET in 1 BOTTLE (62332-586-31) | Amantadine | Alembic Pharmaceuticals Inc. | 2020-10-20 |
| 62332-0586-71 | 500 TABLET in 1 BOTTLE (62332-586-71) | Amantadine | Alembic Pharmaceuticals Inc. | 2020-10-20 |
| 67046-1452-03 | 30 TABLET in 1 BLISTER PACK (67046-1452-3) | Amantadine Hydrochloride | Coupler LLC | 2025-02-07 |
| 67046-1531-03 | 30 TABLET in 1 BLISTER PACK (67046-1531-3) | Amantadine | Coupler LLC | 2025-03-13 |
| 71765-0009-01 | 2 BLISTER PACK in 1 BOX (71765-009-01) / 12 TABLET in 1 BLI... | AMANTADINE HYDROCHLORIDE | Zhejiang Jutai Pharmaceutical Co., Ltd. | 2024-09-26 |
| 72189-0535-30 | 30 TABLET in 1 BOTTLE (72189-535-30) | Amantadine HCL | Direct_Rx | 2024-02-23 |
| 72189-0535-90 | 90 TABLET in 1 BOTTLE (72189-535-90) | Amantadine HCL | Direct_Rx | 2024-02-23 |
| 82804-0267-20 | 20 TABLET in 1 BOTTLE (82804-267-20) | Amantadine | Proficient Rx LP | 2026-02-18 |
Observed labelers:
Marlex Pharmaceuticals Inc (4) ·
Upsher-Smith Laboratories, LLC (3) ·
Alembic Pharmaceuticals Inc. (2) ·
Alembic Pharmaceuticals Limited (2) ·
Coupler LLC (2) ·
Direct_Rx (2)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.